Safety profile of the newly registered swine influenza vaccine Respiporc® FLUpan H1N1
Stefan Pesch, Vicky Fachinger
Evaluation of the genetic diversity of H1pdm Influenza field viruses in respect to Respiporc® FLUpan H1N1
Stefan Pesch, Vicky Fachinger
Efficacy of Respiporc® FLUpan H1N1 under field conditions
Stefan Pesch, Vicky Fachinger
Development of a monovalent pig vaccine based on a human pandemic H1N1 (2009) strain
Stefan Pesch , Vicky Fachinger
Collaboration in more than 46 countries.
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
Warning Message
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.